Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
73.34 USD | +0.11% | +8.66% | +26.73% |
15:19 | BOSTON SCIENTIFIC CORPORATION : Redburn Atlantic bekräftigt seine neutrale Bewertung | ZM |
00:21 | Edwards Lifesciences übertrifft im ersten Quartal dank starker Herzklappen die Schätzungen | RE |
ETFs investiert in Boston Scientific Corporation
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
2,26% | 12 M€ | +15.09% | - | |
1,98% | 1 M€ | +2.21% | - | |
1,75% | 18 M€ | +3.79% | - | |
1,23% | 2 M€ | -1.17% | - | |
1,08% | 16 M€ | -8.49% | ||
1,03% | 10 M€ | +6.14% | - | |
0,78% | 282 M€ | +3.09% | - | |
0,66% | 9 M€ | -.--% | - | |
0,62% | 5 M€ | -72.95% | - | |
0,47% | 717 M€ | +5.83% | ||
0,38% | 26 M€ | +2.00% | - | |
0,37% | 2 M€ | +6.77% | ||
0,37% | 26 M€ | +16.85% | - | |
0,35% | 40 M€ | -.--% | ||
0,28% | 1 M€ | +0.04% | ||
0,27% | 36 M€ | +1.20% | - | |
0,26% | 559 M€ | +14.30% | - | |
0,26% | 1 848 M€ | +18.39% | - | |
0,24% | 9 M€ | +2.34% | - | |
0,24% | 736 M€ | +6.09% | ||
0,22% | 27 M€ | +17.28% | - | |
0,22% | 1 174 M€ | +23.54% | ||
0,22% | 273 M€ | -.--% | ||
0,22% | 655 M€ | -.--% | - | |
0,21% | 6 M€ | +17.98% | - | |
0,21% | 125 M€ | +3.36% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+26.73% | 108 Mrd. | |
+7.71% | 218 Mrd. | |
+6.25% | 182 Mrd. | |
+10.60% | 132 Mrd. | |
+15.42% | 52.98 Mrd. | |
-1.89% | 47.59 Mrd. | |
-1.91% | 39.96 Mrd. | |
+11.16% | 39.22 Mrd. | |
+6.63% | 26.94 Mrd. | |
-13.06% | 19.28 Mrd. |
- Börse
- Aktien
- 884113 Aktie
- ETFs Boston Scientific Corporation